Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/1992
06/09/1992CA1302890C Stable ophthalmic preparations containing acetazolamide
06/09/1992CA1302889C Pharmaceutical composition containing 4-(2-naphthylmethoxy) piperidine
06/09/1992CA1302888C Therapeutic agent for the treatment of disorders associated with cerebral ischemia
06/09/1992CA1302886C Pharmaceutical composition containing a benzodiazepin derivative
06/09/1992CA1302879C Composition having reduced nephrotoxicity comprising a fatty acid containing component and cyclosporine
06/08/1992WO1992010504A2 Phosphonic acid derivatives useful as antiinflammatory agents
06/08/1992WO1992010474A1 3-[2-chloro-4-(trifluoromethyl)phenoxy]-1-azetidine carboxamides having anticonvulsant activity
06/08/1992WO1992010172A1 Solid dosage forms of almokalant and processes for manufacture thereof
06/08/1992WO1992010099A1 Excitatory amino acid antagonists
06/08/1992CA2097910A1 Excitatory amino acid antagonists
06/08/1992CA2097835A1 3-[2-chloro-4-(trifluoromethyl)phenoxy]- 1-azetidine carboxamides having anticonvulsant activity
06/08/1992CA2097178A1 Solid dosage forms of almokalant and processes for manufacture thereof
06/08/1992CA2094123A1 Phosphonic acid derivatives useful as antiinflammatory agents
06/08/1992CA2057181A1 Scrotonergic .alpha.-oxoacetamide
06/08/1992CA2057157A1 Use of interferon and a substance with an antimalarial activity for the treatment of malaria infections
06/08/1992CA2057089A1 Substituted pyrazolopyrimidines and imidazopyridazines as angiotensin ii antagonists
06/08/1992CA2056970A1 Antitumoral and antiviral compound
06/08/1992CA2056967A1 Use of organic compounds
06/08/1992CA2056957A1 Nutrition
06/08/1992CA2056809A1 Benzodiazepine analogs
06/07/1992WO1992010999A1 Substance that can stop bleeding in surgical, medical and dental uses/substance powder 001 that can stop bleeding during surgery, after surgery, medicine, dentistry or any bleeding due to any causes
06/07/1992WO1992010205A1 Synergistic compositions of soluble complement receptors and compounds that inhibit complement and/or suppress immune activity
06/07/1992WO1992010096A1 Compounds that inhibit complement and/or suppress immune activity
06/07/1992CA2097826A1 Compounds that inhibit complement and/or suppress immune activity
06/07/1992CA2097825A1 Synergistic compositions of soluble complement receptors and compounds that inhibit complement and/or suppress immune activity
06/07/1992CA2056894A1 Use of carbazones as novel active ingredients in medicaments
06/07/1992CA2031667A1 Indoleacetic acid derivatives, process for their preparation, and medicines containing same as active ingredients
06/06/1992WO1992010228A1 Devices for treating pulmonary vasoconstriction and asthma
06/06/1992WO1992010173A1 Pharmaceutical compositions
06/06/1992CA2097495A1 Pharmaceutical compositions
06/06/1992CA2056922A1 Tetralones with pharmacological activity
06/06/1992CA2056874A1 Substituted n-benzoyl-n'-(2-phenylethyl)-piperazines
06/06/1992CA2056845A1 Chroman derivatives
06/06/1992CA2056808A1 Hydroxyquinolone derivatives
06/06/1992CA2055376A1 Method of treating shock using a potassium channel activator
06/06/1992CA2038845A1 An agent for reducing the growth of or removing the hair on the human body
06/05/1992WO1992010199A1 Therapeutic and diagnostic applications of fetal fibronectin
06/05/1992CA2075300A1 Therapeutic and diagnostic applications of fetal fibronectin
06/05/1992CA2056746A1 Cosmetic composition
06/04/1992WO1992009616A1 Enhancement of musculature in animals
06/04/1992WO1992009565A1 Peptidyl derivatives
06/04/1992WO1992009564A1 Peptidyl derivatives
06/04/1992DE4038385A1 Sitosterol and its glycoside(s) with improved bio-availability - are in the form of microemulsions using lecithin as the carrier, isopropyl-myristate as the emulsifier and isopropanol as co-emulsifier
06/04/1992DE4038335A1 Neue pyridinderivate, verfahren zu ihrer herstellung und verwendung als arzneimittel Last pyridine derivatives, process for their production and use as a drug
06/04/1992DE4038203A1 Pharmaceutical spray-prepn. for admin. of nitrate(s) - esp. for treatment of cardiovascular, disorders, asthma, migraine and colic
06/04/1992DE4038128A1 8-en-19, 11(beta)-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate 8-ene-19, 11 (beta) -ueberbrueckte steroids, their production and pharmaceutical compositions containing them
06/04/1992CA2097590A1 Enhancement of musculature in animals
06/04/1992CA2073513A1 Peptidyl derivatives
06/04/1992CA2073510A1 Peptidyl derivatives
06/04/1992CA2056878A1 N,o-sulphated heparosans, process for preparing them and pharmaceutical compositions containing them
06/04/1992CA2056201A1 Treatment of sleep disorders
06/03/1992EP0488959A2 New uses of competitive NMDA receptor antagonists
06/03/1992EP0488928A2 Pharmaceutical formulations containing a mixture of higher primary aliphatic alcohols in the treatment of hypercholesterolaemia and hyperlypoproteinaemia type II and stimulation of sexual behavior in animals and humans
06/03/1992EP0488897A1 New guanidine derivatives, process for their preparation and pharmaceutical compositions containing them
06/03/1992EP0488800A2 Corandomized fat compositions for infant formulas
06/03/1992EP0488663A1 Pyrrolo[2,3-d]azepine derivatives, process for their preparation and pharmaceutical compositions containing them
06/03/1992EP0488602A1 Aryl derivatives
06/03/1992EP0488589A1 Process for producing kappa-casein glycomacropeptides
06/03/1992EP0488532A1 Indole- and benzimidazole-substituted imidazole and benzimidazole derivatives
06/03/1992EP0488513A2 Use of dioxabicyclo [3.3.0]octane derivatives for the manufacture of a medicament for inhibiting the metabolism of cholesterol.
06/03/1992EP0488435A1 Method of increasing the muscle/fat ratio in agricultural domestic animals
06/03/1992EP0488401A1 A controlled-release pharmaceutical preparation for intra-ocular implant
06/03/1992EP0488383A1 2-beta,19-ethylene bridged steroids as aromatase inhibitors
06/03/1992EP0488345A1 1,4-Dihydropyridine derivatives and methods of producing the same
06/03/1992EP0488227A2 Optically active pyridobenzoxazine derivatives
06/03/1992EP0488210A1 Process for preparing 1,5-benzothiazepine derivative
06/03/1992EP0488209A1 Process for producing benzylphthalazinone derivatives and salts thereof
06/03/1992EP0488181A1 Hard capsule preparation containing nifedipine
06/03/1992EP0488169A1 Beta-Hydroxyethylamines with a 1,1-disubstituted cyclopropyl-group, process for their preparation and use
06/03/1992EP0488139A1 Pharmaceutical composition comprising calcium polycarbophil
06/03/1992EP0488137A2 Preparation for transdermal drug administration
06/03/1992EP0488107A2 Tricyclic benzodiazole analogs and their use in the treatment of cardiovascular disorders
06/03/1992EP0488089A1 Diclofenac preparations for topical use
06/03/1992EP0488079A1 Oxadiazolylmethylpurines, their preparation, and their pharmaceutical use
06/03/1992EP0488078A1 Diet free of phenylalanin for juveniles and adults affected with phenylketonurea
06/03/1992EP0488059A2 Use of a combination of an ace inhibitor with a calcium antagonist in the treatment of proteinuria
06/03/1992EP0488044A1 An imidazobenzodiazepin for treating sleep disorders
06/03/1992EP0488009A2 Piperidinoalkyl-benzoxazine-and-thiazine-compounds, processes for their preparation and drugs containing them
06/03/1992EP0488008A1 Heterocyclic substituted piperazinoalkylbenzoxazine and -thiazine compounds, process for their preparation and therapeutic drugs containing them
06/03/1992EP0487996A2 Cephalosporins substituted in position 3, process for their preparation and their use as medicine
06/03/1992EP0487980A1 Aminodiols-derivatives
06/03/1992EP0487973A1 Topical lotion containing Niclosamide
06/03/1992EP0487930A1 Process for preparing benzo[C]phenanthridinium derivatives, and novel compounds prepared by said process
06/03/1992EP0487768A1 Pharmaceutical composition with improved dissolution property
06/03/1992EP0487729A1 Ketotifen preparation for external use
06/03/1992EP0487718A1 NUCLEIC ACID PROBES with negatively charged haptens which are attached to the probe via a hydrazine binding moiety
06/03/1992EP0487673A1 New xanthine derivatives
06/03/1992EP0487632A1 Stabilized vaccine compositions
06/03/1992EP0487623A1 Derivatives of 5-amino-1,2,3,4 tetrahydro-acridine and applications as drugs
06/03/1992EP0487620A1 Novel amino acid derivatives, method for preparing them, and their therapeutical applications.
06/03/1992EP0487603A1 Composition based on hydrated lipidic lamelar phases or on liposomes containing at least one derivative of labdane, or a plant extract containing it; cosmetic or pharmaceutical, particularly dermatological composition containing it.
06/03/1992EP0487593A1 Macrocyclic compounds
06/03/1992EP0487575A1 Pharmaceutical formulations.
06/03/1992EP0484446A4 Carnitine supplemented finishing pig diet
06/03/1992EP0467954A4 Preparation of liposome and lipid complex compositions
06/03/1992EP0219539B1 Transdermal nitroglycerin delivery system
06/03/1992CN1061602A Process for preparing 7-acyl-3-(substituted carbambytoxy) cephem compound
06/03/1992CN1061601A Preparation method of tripterygium wilforbii and its use of antifertility
06/03/1992CN1061600A Chemical process
06/03/1992CN1061595A Heterocyclic compounds ad antagonists of excitatory amino acid receptors, processes for their preparation and their use